Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: art slott who wrote (674)	3/21/1998 4:35:00 PM
From: vestor	Read Replies (2) \| Respond to of 1837

I seriously believe they will get the Cenestin approval by years end. We could well see $20 - 25 per share by years end.....there is a lot of pressure on the FDA to not get political on this one....I would not short here however I would wait for the CNBC story to fade from memory and pick-up DRMD at or about a 50% retracement.....We may have a rel winner here at last....

To: art slott who wrote (674)	3/22/1998 6:15:00 PM
From: Doug Bean	Read Replies (1) \| Respond to of 1837

Art: I sure hope you are right .. All these shorts and traders have made me nervous. I really don't want to sell anything right now , but a guy might feel foolish if it runs to 7 and drops back to 5.5 in a day or so. i do tend to think that it will drop back ,, but only to around 5.75 to 6 , which if that were the case it wouldn't pay to sell taking into consideration taxes etc. No, I think this might be a case where the comapny is now "over the hump" and while its not straight up from here ,it could be just up. Also you point aboout a takeover is valid. I'd REALLY feel the fool part if after all this time i was out of the stock during a take over. CRDoug